Dr Boreham’s Crucible: Starpharma looks to DEP-art from the pack with a tighter focus

As with a stand-up comedian performing before an audience of accountants – or, even worse, actuaries – drug developers face a tough crowd.

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.ntnews.com.au)